Literature DB >> 16100703

Neuropathogenesis in cytomegalovirus infection: indication of the mechanisms using mouse models.

Yoshihiro Tsutsui1, Isao Kosugi, Hideya Kawasaki.   

Abstract

Cytomegalovirus (CMV) is the most frequent infectious cause of developmental brain disorders and also causes brain damage in immunocompromised individuals. Although the brain is one of the main targets of CMV infection, little is known about the neuropathogenesis of the brain disorders caused by CMV in humans because of the limitations in studying human subjects. Murine CMV (MCMV) is similar to human CMV (HCMV) in terms of genome structure, pattern of gene expressions, cell tropism and infectious dynamics. In mouse models, it has been shown that neural stem/progenitor cells are the most susceptible to CMV infection in developing brains. During brain development, lytic infection tends to occur in immature glial cells, presumably causing structural disorders of the brain. In the prolonged phase of infection, CMV preferentially infects neuronal cells. Infection of neurons may tend to become persistent by evasion of immune reactions, anti-apoptotic effects and neuron-specific activation of the e1-promoter, presumably causing functional neuronal disorders. It has also been shown that CMV infection in developing brains may become latent in neural immature cells. Brain disorders may occur long after infection by reactivation of the latent infection. Copyright (c) 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2005        PMID: 16100703     DOI: 10.1002/rmv.475

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  30 in total

1.  Maintenance of large numbers of virus genomes in human cytomegalovirus-infected T98G glioblastoma cells.

Authors:  Ying-Liang Duan; Han-Qing Ye; Anamaria G Zavala; Cui-Qing Yang; Ling-Feng Miao; Bi-Shi Fu; Keun Seok Seo; Christian Davrinche; Min-Hua Luo; Elizabeth A Fortunato
Journal:  J Virol       Date:  2014-01-22       Impact factor: 5.103

Review 2.  Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis.

Authors:  Mark R Schleiss
Journal:  Infect Disord Drug Targets       Date:  2011-10

3.  Comparison of DNA extraction methods from small samples of newborn screening cards suitable for retrospective perinatal viral research.

Authors:  Gai L McMichael; Amanda R Highet; Catherine S Gibson; Paul N Goldwater; Michael E O'Callaghan; Emily R Alvino; Alastair H MacLennan
Journal:  J Biomol Tech       Date:  2011-04

4.  Murine cytomegalovirus IE3 protein interacts with Ankrd17.

Authors:  Hui Wang; Xinglou Liu; Sainan Shu; Ju Zhang; Yongjian Huang; Feng Fang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-06-14

Review 5.  Neonatal seizures: controversies and challenges in translating new therapies from the lab to the isolette.

Authors:  Kevin E Chapman; Yogendra H Raol; Amy Brooks-Kayal
Journal:  Eur J Neurosci       Date:  2012-06       Impact factor: 3.386

6.  Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?

Authors:  Mark R Schleiss
Journal:  Future Virol       Date:  2013-12       Impact factor: 1.831

7.  Bystander attenuation of neuronal and astrocyte intercellular communication by murine cytomegalovirus infection of glia.

Authors:  Winson S C Ho; Anthony N van den Pol
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

8.  An in vitro mouse model of congenital cytomegalovirus-induced pathogenesis of the inner ear cochlea.

Authors:  Michael Melnick; Tina Jaskoll
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-12-26

9.  Glycoprotein B (gB) vaccines adjuvanted with AS01 or AS02 protect female guinea pigs against cytomegalovirus (CMV) viremia and offspring mortality in a CMV-challenge model.

Authors:  Mark R Schleiss; K Yeon Choi; Jodi Anderson; Janine Gessner Mash; Martine Wettendorff; Sally Mossman; Marc Van Damme
Journal:  Vaccine       Date:  2013-07-16       Impact factor: 3.641

10.  Nuclear factor κB activation impairs ependymal ciliogenesis and links neuroinflammation to hydrocephalus formation.

Authors:  Michael Lattke; Alexander Magnutzki; Paul Walther; Thomas Wirth; Bernd Baumann
Journal:  J Neurosci       Date:  2012-08-22       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.